Welcome to our dedicated page for Fabrinet SEC filings (Ticker: FN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fabrinet filings document the company’s operating results, financial condition, governance matters and shareholder actions as a Cayman Islands registrant listed under the FN symbol. Its Form 8-K reports furnish quarterly and annual financial results press releases and also record material governance events, including board appointments, director retirements and executive incentive compensation arrangements.
Proxy materials and annual meeting reports disclose board elections, auditor ratification, advisory executive compensation votes, ordinary-share voting results and meeting procedures. Together, these filings provide formal records of Fabrinet’s manufacturing-services business disclosures, capital and shareholder structure, compensation oversight and public-company governance.
Fabrinet (FN) Form 144 notice: The filer reports a proposed sale of 3,200 ordinary shares through Citigroup Global Markets, Inc. on the NYSE with an aggregate market value of $1,069,440.00 and an approximate sale date of 08/29/2025. The shares were acquired on 08/29/2025 by vesting from a share account and were received as compensation. The filing indicates no securities sold by the reporting person in the past three months and includes the required representation that the seller is unaware of undisclosed material adverse information about the issuer.
Filer submitted a Form 144 reporting proposed sales of 13,000 ordinary shares of Fabrinet (FN) through Citigroup Global Markets, with an aggregate market value of $4,568,200.00 and an approximate sale date of 08/28/2025. The filing states these shares were acquired on 08/28/2025 via restricted stock vesting from Fabrinet and were issued as payment for services rendered. The filing also discloses a prior sale by the same account of 10,000 shares on 08/25/2025 generating $3,106,786.92 in gross proceeds. The filer certifies they possess no undisclosed material adverse information.
Form 144 notice for Fabrinet (FN) indicates a proposed sale of 9,513 ordinary shares through Bay Crest Partners on the NYSE with an aggregate market value of 3,145,569 and approximately 35,729,581 shares outstanding. The shares to be sold were acquired by the selling person as vested RSU and PSU grants on 08/19/2023 (2,599 shares), 08/20/2023 (4,392 shares) and 08/24/2024 (2,522 shares), matching the total offered for sale.
The notice reports no securities sold by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer. The form identifies the broker, planned approximate sale date of 08/27/2025, and nature of payment as vesting of equity awards.
Fabrinet (FN) submitted a Rule 144 notice reporting a proposed sale of 1,200 ordinary shares through Citigroup Global Markets, valued at $402,150, with an approximate sale date of 08/27/2025 on the NYSE. The filer acquired the shares on 01/02/2024 by restricted stock vesting from Fabrinet and lists the payment nature as services rendered.
The filing shows there were 35,728,074 shares outstanding, so the 1,200-share sale represents a very small fraction of the company. No other securities were reported sold in the past three months, and the notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Csaba Sverha, Chief Financial Officer of Fabrinet (FN), reported insider transactions reducing his holdings. Restricted share units were withheld for taxes in two transactions on 08/22/2025 and 08/24/2025 (217 and 321 shares). On 08/25/2025 the reporting person sold a total of 10,000 ordinary shares in three trades at weighted-average prices of approximately $309.88, $310.96, and $311.70. Following these transactions the filing shows 21,552 shares beneficially owned. The Form 4 includes explanations that the withheld shares covered tax liabilities related to RSU vesting and provides weighted-average price ranges for the sales.
Seamus Grady, who is identified as both Director and Chief Executive Officer of Fabrinet (FN), reported two routine sales of company stock to satisfy tax obligations tied to vested restricted share units. On 08/22/2025 he disposed of 1,817 ordinary shares at $294.35 per share, leaving 58,474 shares beneficially owned. On 08/24/2025 he disposed of 2,937 shares at the same price, leaving 55,537 shares. The filing states these shares were withheld to cover the reporting person’s tax liability related to RSU vesting. The form was signed by an attorney-in-fact, Andrew Chew, on 08/26/2025.
Harpal Gill, President & COO and Director of Fabrinet (FN), reported disposition of shares withheld to cover taxes on vested restricted share units. The Form 4 shows two withholding events: 1,165 shares were surrendered on 08/22/2025 and 1,836 shares on 08/24/2025, both at a price of $294.35 per share. Following the transactions the reporting person’s direct beneficial ownership declined from 30,022 shares to 28,186 shares. The filing identifies the dispositions as tax-withholding for RSU vesting rather than open-market sales.
Fabrinet (FN) insider sale by EVP Edward T. Archer. The filing shows Mr. Archer, listed as EVP, Sales & Marketing, disposed of company stock in two transactions: 548 ordinary shares on 08/22/2025 at $294.35 and 848 ordinary shares on 08/24/2025 at $294.35. After the 08/22 transaction his reported beneficial ownership was 14,025 shares and after the 08/24 transaction it was 13,177 shares, with ownership reported as direct. The form explains these shares were withheld to cover the reporting person's tax liability on vested Restricted Share Units. The Form 4 was signed by Andrew Chew as attorney-in-fact on 08/26/2025.
Edward T. Archer, Executive Vice President, Sales & Marketing of Fabrinet (FN), reported receipt of 3,033 restricted share units (RSUs) on 08/21/2025 at a reported price of $0, increasing his total beneficial ownership to 14,573 ordinary shares. The RSUs are structured to vest in three equal annual installments on August 21, 2026, 2027 and 2028, subject to his continued service with the company through each vesting date. The Form 4 was signed by Andrew Chew as attorney-in-fact on 08/25/2025. The filing documents a non-derivative award of RSUs intended as equity compensation that will convert to ordinary shares over three years if service conditions are met.
Fabrinet (FN) Chief Financial Officer Csaba Sverha reported an acquisition of 3,754 restricted share units (RSUs) on 08/21/2025, increasing his beneficial ownership to 32,090 ordinary shares. The RSUs carry a $0 purchase price and vest in three equal annual installments on each of August 21, 2026, 2027 and 2028, contingent on continued service with the company. The filing indicates the transaction was reported on Form 4 and was executed by an attorney-in-fact on behalf of the reporting person.